Serotonin Syndrome for ICU Nurses 2026 — Clonus, Fever, and the Drug Combinations That Cause It

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Serotonin syndrome is one of the few life-threatening drug reactions that is almost entirely preventable and almost entirely reversible — if it is recognized. It is a clinical diagnosis, not a lab one, and the nurse at the bedside is usually the first person positioned to connect a new medication, a rising temperature, and a patient whose legs won't stop jerking. Because the treatment can be as simple as stopping the offending drug and controlling agitation and temperature, catching it early changes the entire trajectory.

The short version: Serotonin syndrome is caused by too much serotonin activity, usually from combining serotonergic drugs or adding one to another. The classic picture is a triad: altered mental status, autonomic instability (fever, tachycardia, hypertension, diaphoresis), and neuromuscular excitation — and the neuromuscular signs, especially clonus that is worse in the legs and hyperreflexia, are what separate it from its mimics. Treatment is stop the drug, cool, sedate with benzodiazepines, and in severe cases give cyproheptadine. Onset is usually within 24 hours of a change.

What actually causes it

Serotonin syndrome is a predictable consequence of excess serotonin at nerve synapses, not an idiosyncratic allergy. It most often appears when two serotonergic agents are combined, or when a dose is increased. The list of culprits is long and includes SSRIs and SNRIs, MAO inhibitors, tramadol, meperidine, fentanyl, ondansetron, linezolid, methylene blue, triptans, lithium, and many drugs of abuse. Some of the most dangerous combinations are ones that hide in routine ICU care — a patient on an antidepressant who then receives fentanyl, linezolid, or methylene blue for vasoplegia. Because so many of these agents live on the ICU pump and code cart, the syndrome is genuinely a critical-care problem, not just a psychiatry one.

The triad — and why the legs give it away

The diagnosis rests on three overlapping domains. Not every patient shows all three, and milder cases can look like simple agitation or a fever workup, which is exactly why it gets missed.

Domain	What you see
Mental status	Agitation, restlessness, anxiety, confusion, and in severe cases delirium.
Autonomic instability	Fever (can be extreme), tachycardia, hypertension, diaphoresis, dilated pupils, flushing, diarrhea.
Neuromuscular excitation	Tremor, hyperreflexia, myoclonus, rigidity, and clonus that is greater in the lower extremities — the single most useful sign.

The neuromuscular findings are the fingerprint. A patient with spontaneous or inducible clonus, brisk reflexes, and tremor — more pronounced in the legs than the arms — in the setting of a serotonergic drug is serotonin syndrome until proven otherwise. The widely used Hunter criteria formalize this: in someone taking a serotonergic agent, findings such as spontaneous clonus, inducible clonus with agitation or diaphoresis, ocular clonus, tremor with hyperreflexia, or hypertonia with a temperature above 38°C make the diagnosis.

Telling it apart from its mimics

Three hyperthermic syndromes get confused at the bedside, and the treatments diverge, so distinguishing them matters. The timeline and the muscle exam do most of the work.

Feature	Serotonin syndrome	NMS	Malignant hyperthermia
Trigger	Serotonergic drug added/increased	Dopamine blocker (antipsychotic) or dopamine agonist withdrawal	Volatile anesthetic or succinylcholine
Onset	Hours (<24 h)	Days to 1–2 weeks	Minutes, intraoperative
Muscles	Clonus, hyperreflexia (legs > arms)	"Lead-pipe" rigidity, hyporeflexia	Rigidity, masseter spasm, rising EtCO2
Bedside key	Clonus + brisk reflexes	Bradyreflexia + rigidity	Anesthesia exposure + EtCO2

See the neuroleptic malignant syndrome and malignant hyperthermia guides for the full comparison — the practical rule is that clonus and hyperreflexia point to serotonin, rigidity with slow reflexes points to NMS, and an anesthetic exposure with a climbing end-tidal CO2 points to MH.

What kills these patients

Hyperthermia is the emergency, not the diagnosis. Severe serotonin syndrome drives sustained muscle activity that generates heat faster than the body can dump it. Temperatures above roughly 41°C threaten the same cascade seen in heat stroke: rhabdomyolysis, acute kidney injury, DIC, seizures, and metabolic acidosis. In this setting, the priority is aggressive cooling and stopping the muscle activity — often with deep sedation, and in the most severe cases intubation and paralysis — not waiting for antipyretics that don't address the mechanism.

Treatment — simple when caught early

The backbone of care is straightforward. Stop every serotonergic agent and provide supportive care: IV fluids, continuous monitoring, and control of temperature and vitals. Benzodiazepines are first-line for agitation, tremor, and mild hyperthermia because they blunt the muscle overactivity that drives heat. Control hypertension and tachycardia with short-acting, titratable agents rather than long-acting drugs, since the autonomic swings can reverse quickly. For moderate-to-severe cases that don't settle, cyproheptadine — an oral/enteral serotonin antagonist — is the specific agent. The sickest, hyperthermic, rigid patients need intubation, sedation, and neuromuscular blockade with a non-depolarizing agent to stop heat production, followed by active cooling.

Your leverage is the medication history and the muscle exam. When a patient spikes a fever with agitation, tachycardia, and tremor, scan the MAR for serotonergic agents — recently started or dose-changed — and check for clonus and brisk reflexes, worse in the legs. Flag the combination to the team, hold further serotonergic drugs, and start benzodiazepines and cooling early. Avoid bromocriptine and dantrolene here (those belong to NMS/MH), and avoid physical restraints alone, which can worsen the hyperthermia and lactic acidosis by increasing isometric muscle work.

The nursing bottom line

Serotonin syndrome is a preventable, reversible emergency that hides inside ordinary ICU pharmacology. It shows up within a day of adding or increasing a serotonergic drug, and it announces itself through the muscles: clonus and hyperreflexia that are worse in the legs, on a background of agitation and autonomic instability. Recognize the triad, use the Hunter criteria, and separate it from NMS and malignant hyperthermia by the muscle exam and the trigger. Then act on what you can control — stop the offending drugs, sedate with benzodiazepines, cool aggressively, and escalate to cyproheptadine or intubation and paralysis if the temperature and rigidity climb. The nurse who links a new medication to a jerking, febrile patient is the person who turns a potential ICU death into a two-day admission.

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.